Lithium carbonate

Lithium carbonate
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Overview

Lithium carbonate is a mood Stabilizer that is FDA approved for the {{{indicationType}}} of bipolar disorder, maintenance therapy and manic episode. Common adverse reactions include acne, hypothyroidism, weight increased, gastritis, nausea, xerostomia, leukocytosis, fine tremor, hyperreflexia, deep tendon, nephrotoxicity, polyuria, increased thirst..

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

• Bipolar disorder, maintenance therapy

• Maintenance 900 to 1200 mg/day PO in 2 to 3 divided doses

• Bipolar disorder, manic episode

• 1800 mg/day PO in 2 to 3 divided doses

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information about Off-Label Guideline-Supported Use of Lithium carbonate in adult patients.

Non–Guideline-Supported Use

There is limited information about Off-Label Non–Guideline-Supported Use of Lithium carbonate in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

• Safety below the age of 12 have not been established.

B*ipolar disorder, maintenance therapy

• 12 yr and older, extended-release tablets, maintenance, 900 to 1200 mg/day ORALLY in 2 to 3 divided doses; desired serum lithium levels ranging between 0.6 to 1.2 mEq/L

• Bipolar disorder, maintenance therapy

• Immediate-release tablet and capsule formulations, maintenance, 300 mg PO 3 to 4 times daily

Bipolar disorder, manic episode

• 12 yr and older, extended-release tablets, acute mania, 1800 mg/day PO in 2 to 3 divided doses

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information about Off-Label Guideline-Supported Use of Lithium carbonate in pediatric patients.

Non–Guideline-Supported Use

There is limited information about Off-Label Non–Guideline-Supported Use of Lithium carbonate in pediatric patients.

Contraindications

There is limited information regarding Lithium carbonate Contraindications in the drug label.

Warnings

There is limited information regarding Lithium carbonate Warnings' in the drug label.

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Lithium carbonate Clinical Trials Experience in the drug label.

Postmarketing Experience

There is limited information regarding Lithium carbonate Postmarketing Experience in the drug label.

Drug Interactions

There is limited information regarding Lithium carbonate Drug Interactions in the drug label.

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA): There is no FDA guidance on usage of Lithium carbonate in women who are pregnant.
Pregnancy Category (AUS): There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Lithium carbonate in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Lithium carbonate during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Lithium carbonate in women who are nursing.

Pediatric Use

There is no FDA guidance on the use of Lithium carbonate in pediatric settings.

Geriatic Use

There is no FDA guidance on the use of Lithium carbonate in geriatric settings.

Gender

There is no FDA guidance on the use of Lithium carbonate with respect to specific gender populations.

Race

There is no FDA guidance on the use of Lithium carbonate with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Lithium carbonate in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Lithium carbonate in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Lithium carbonate in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Lithium carbonate in patients who are immunocompromised.

Administration and Monitoring

Administration

There is limited information regarding Lithium carbonate Administration in the drug label.

Monitoring

There is limited information regarding Lithium carbonate Monitoring in the drug label.

IV Compatibility

There is limited information regarding the compatibility of Lithium carbonate and IV administrations.

Overdosage

There is limited information regarding Lithium carbonate overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.

Pharmacology

There is limited information regarding Lithium carbonate Pharmacology in the drug label.

Mechanism of Action

There is limited information regarding Lithium carbonate Mechanism of Action in the drug label.

Structure

There is limited information regarding Lithium carbonate Structure in the drug label.

Pharmacodynamics

There is limited information regarding Lithium carbonate Pharmacodynamics in the drug label.

Pharmacokinetics

There is limited information regarding Lithium carbonate Pharmacokinetics in the drug label.

Nonclinical Toxicology

There is limited information regarding Lithium carbonate Nonclinical Toxicology in the drug label.

Clinical Studies

There is limited information regarding Lithium carbonate Clinical Studies in the drug label.

How Supplied

There is limited information regarding Lithium carbonate How Supplied in the drug label.

Storage

There is limited information regarding Lithium carbonate Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Lithium carbonate |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Lithium carbonate |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Lithium carbonate Patient Counseling Information in the drug label.

Precautions with Alcohol

Alcohol-Lithium carbonate interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

There is limited information regarding Lithium carbonate Brand Names in the drug label.

Look-Alike Drug Names

There is limited information regarding Lithium carbonate Look-Alike Drug Names in the drug label.

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.